Results 101 to 110 of about 951,374 (223)

Adverse events Following Immunization with Fractional one-fifth and one-half doses of Yellow Fever Vaccine compared to full dose in children 9–23 months old in Uganda — Preliminary report

International Journal of Infectious Diseases
Background: In 2016, the World Health Organization recommended that a fractional dose of yellow fever vaccine could be used in persons 2 years of age or older in response to an emergency situation that resulted in a global shortage of available yellow ...
Ms Ellon Twinomuhwezi, Dr. Rebecca M Casey, Dr. Conrad Tumwine, Ms Angela Namwanje, Dr. Winfred Nansozi Nakato, Dr. Arthur Brian Sekiziyivu, Mrs Marjorie Sserunga Najjengo, Dr. Irene Lubega, Dr. Immaculate Ampeire, Ms Alexandra Tuttle, Ms Susan Y. Chub Susan Y Chub, Ms Reena H. H Doshi, Dr. Andrew Kambugu, Dr. Jane F Gidudu   +13 more
doaj   +1 more source

The Baboon as a Model to Study Human Health and Complex Disease

American Journal of Primatology, Volume 88, Issue 9, September 2026.
Baboons remain underappreciated as models of human biology and disease offering a distinct combination of biological and practical properties. In this review, we evaluate the baboon as a model for human complex diseases and make the case for broader use of baboons in translational research.
Brittany Hazzard, Yoav Gilad
wiley   +1 more source

Yellow fever scratch vaccine

, 1957
6 ...
World Health Organization, WHO Expert Committee on Yellow Fever Vaccine, Macnamara, F.N.   +2 more
core  

Eugenol‐Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights

Journal of Medical Virology, Volume 98, Issue 9, September 2026.
ABSTRACT Arboviruses represent an ongoing global health challenge, particularly in tropical regions where diseases caused by Chikungunya virus (CHIKV) and Mayaro virus (MAYV) continue to emerge. Given the absence of licensed antiviral therapies, the identification of effective small molecules remains critical.
Adriana Cotta Cardoso Reis, Amália Luíza de Sousa da Silva, Camila Portruneli, Augusto Vieira Pontes Silva, Saulo Fehelberg Pinto Braga, Igor Rodrigues Lapa, Thiago Belarmino de Souza, Lucas Lopardi Franco, Diogo Teixeira Carvalho, Geraldo Célio Brandão   +9 more
wiley   +1 more source

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains

Vaccines
Background/Objectives: Chimpanzee adenoviral-vectored vaccines have proven to be both safe and effective, with a manufacturing and distribution pipeline capable of rapid global supply, as demonstrated during the COVID-19 pandemic.
Marta Ulaszewska, Ji Ma, Susan J. Morris, Sophie M. Jegouic Goodall, Winnie Kerstens, Hendrik Jan Thibaut, Lotte Coelmont, Kai Dallmeier, Sarah C. Gilbert, Barbara Dema   +9 more
doaj   +1 more source

Mitigating yellow fever vaccine associated viscerotropic disease in older travellers

, 2020
In the 1930s, the development of a vaccine for humans toprevent or interrupt outbreaks of yellow fever,an acute viral haemorrhagic illness that is endemic in tropicaland sub-tropical areas of Africa, and Central and South America and in Trinidad, was ...
Fletcher, Rachael, Patel, Dipti, Simons, Hilary   +2 more
core   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, Volume 136, Issue S4, Page S7-S17, September 2026.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

Update on yellow fever vaccine supply

Presentations February 2017 Day 2On the agenda, this publication listed as: Update on yellow fever vaccine supply.yellow-fever-02-greenberg ...

core  

Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India

, 2006
Although typhoid fever is confirmed by culture of Salmonella enterica serotype Typhi, rapid and simple diagnostic serologic tests would be useful in developing countries. We examined the performance of Widal test in a community field site and compared it
Kumar Bhattacharya, Sujit, Sur, Dipika, Wain, John, Deen, Jacqueline L, Dutta, Shanta, Sen, Bhaswati, Ochiai, Leon, Deb, Alok Kumar, Clemens, John D, Bhattacharya, Sujit Kumar, von Seidlein, Lorenz, Clemens, John D., Manna, Byomkesh, Deen, Jacqueline L.   +13 more
core   +1 more source

Multi-epitope based vaccine against yellow fever virus applying immunoinformatics approaches

, 2020
Yellow fever disease is considered a re-emerging major health issue which has caused recent outbreaks with a high number of deaths. Tropical countries, mainly African and South American, are the most affected by Yellow fever outbreaks.
Tosta, Stephane Fraga de Oliveira, Passos, Mariana Santana, Salgado, Álvaro, Soares, Siomar C., Vasco Azevedo, Azevedo, Vasco, Rodrigo Kato, Mariana Santana Passos, Xavier, Joilson, Stephane Fraga de Oliveira Tosta, Arun Kumar Jaiswal, Marta Giovanetti, Álvaro Salgado, Joilson Xavier, Siomar C. Soares, Kato, Rodrigo, Tiwari, Sandeep, Luiz Carlos Junior Alcantara, Sandeep Tiwari, Jaiswal, Arun Kumar, Alcantara, Luiz Carlos Junior, Giovanetti, Marta   +21 more
core   +1 more source